Abstract

// Shanqun Jiang 1, 2, * , Scott A. Venners 3, * , Yi-Hsiang Hsu 4, 5 , Justin Weinstock 6 , Suwen Wu 1 , Yanfeng Zou 7 , Faming Pan 7 and Xiping Xu 2, 8 1 School of Life Sciences, Anhui University, Hefei, China 2 Institute of Biomedicine, Anhui Medical University, Hefei, China 3 Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada 4 Institute for Aging Research, HSL and Harvard Medical School, Boston, MA, USA 5 Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA 6 Department of Statistics, University of Virginia, Charlottesville, VA, USA 7 Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China 8 Division of Epidemiology and Biostatistics, University of Illinois at Chicago School of Public Health, Chicago, IL, USA * These authors contributed equally to this work Correspondence to: Shanqun Jiang, email: shanqunjiang2014@163.com Keywords: MTHFR; MTR; polymorphism; lipid; interaction Received: September 11, 2017      Accepted: November 16, 2017      Published: January 04, 2018 ABSTRACT This cross-sectional study investigated the gene-environment interactions between the MTHFR and MTR polymorphisms and gender with regard to lipid profiles in a general Chinese population. We recruited 2,124 individuals from Anhui Province, China. The MTHFR (C677T and A1298C) and MTR (A2756G) polymorphisms were genotyped, and serum lipid levels, including TC, TG, LDL-C, and HDL-C, were determined. Our results showed that male MTR AG + GG genotype carriers had significantly lower serum TC (adjusted β ± [SE]:-0.25 ± 0.10 mmol/L; P = 0.0159), LDL-C (adjusted β ± [SE]:-0.24 ± 0.09 mmol/L; P = 0.0049), and HDL-C (adjusted β ± [SE]:-0.09 ± 0.03 mmol/L; P = 0.0055) levels than the AA carriers. Male MTHFR677TT genotype carriers had significantly higher serum TC (adjusted β±[SE]: 0.28 ± 0.13 mmol/L; P = 0.0287) and LDL-C (adjusted β ± [SE]: 0.26 ± 0.13 mmol/L; P = 0.0485) levels than CC + CT carriers. In subsequent analyses, there was a significant interaction between the MTR AG+GG genotypes and gender in association with TC, LDL-C and TG levels ( P = 0.0378, 0.0054 and 0.0183 for interaction, respectively).The interaction term for the MTHFR 677TT genotype and gender was also significant for TC and LDL-C levels ( P = 0.0147 and 0.0243 for interaction, respectively). Further haplotype analysis showed that there also were significant interactions between gender and hap2 (MTHFR 677C/1298A) on TC ( P = 0.009) and LDL-C ( P = 0.013). We suggest that the negative effects of the MTR and MTHFR genotypes on serum lipids are based on certain gene-environment interactions in the Chinese general population.

Highlights

  • Meta-analysis has shown that an increase of 5 μmol/L in plasma homocysteine (Hcy) levels enhances the lifetime risk of cardiovascular disease (CVD) 1.6- to 1.8-fold, similar to the elevation in risk with an increase of 20 mg/dL (0.52 mmol/L) in cholesterol concentration [1]

  • We suggest that the negative effects of the MTR and methylenetetrahydrofolate reductase (MTHFR) genotypes on serum lipids are based on certain gene-environment interactions in the Chinese general population

  • We aim to examine the crosssectional associations between the MTHFR C677T, MTHFR A1298C, and MTR A2756G functional gene polymorphisms and blood lipid levels, as well as whether interactions between these variants exist on the multiplicative scale with gender in a Chinese general population

Read more

Summary

Introduction

Meta-analysis has shown that an increase of 5 μmol/L in plasma homocysteine (Hcy) levels enhances the lifetime risk of cardiovascular disease (CVD) 1.6- to 1.8-fold, similar to the elevation in risk with an increase of 20 mg/dL (0.52 mmol/L) in cholesterol concentration [1]. A growing body of evidence has found that the risk associated with HHcy and hypercholesterolemia combined is greater than the risk associated with one of these risk factors alone www.impactjournals.com/oncotarget [2]. This suggests that HHcy can accelerate atherosclerosis when associated with elevated plasma lipid levels. Our China Stroke Primary Prevention Trial (CSPPT) subgroup analysis [3] found that, for participants not receiving folic acid treatment, high total cholesterol (TC). Folic acid supplementation for 4.5 years significantly reduced the risk of first stroke by 31% among hypertensive participants with high TC. In the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, which enrolled over 9,000 coronary patients with type 2 diabetes, fenofibrate led to just an 11%

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call